D.E. Shaw & Co’s LifeMD LFMD Stock Holding History

D.E. Shaw & Co’s Portfolio LFMD Stock Details LFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-13,200	Closed	-$90.6K	–	4731
2024 Q2	$90.6K	Hold	13,200	–	–	﹤0.01%	4178
2024 Q1	$136K	Buy	+13,200	New	+$97.6K	﹤0.01%	3973

Other funds holding LFMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

BRF

B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

D.E. Shaw & Co's LFMD Position: Q1 2026 in Review

D.E. Shaw & Co sold out of LifeMD (LFMD) in Q1 2026, closing a stake of 287,398 shares — an estimated $980K sold.

D.E. Shaw & Co first reported a position in LFMD in Q3 2021 and held it in 9 quarters. The position peaked at $16.6M in Q2 2025. 102 funds tracked by Wall St. Rank hold LFMD as of Q1 2026.

D.E. Shaw & Co reported no remaining LifeMD position as of Q1 2026 after selling out during the quarter.
D.E. Shaw & Co sold 287,398 LifeMD shares in Q1 2026, an estimated $980K.
D.E. Shaw & Co first reported a position in LifeMD in Q3 2021 and held it in 9 quarters.
D.E. Shaw & Co's LifeMD position peaked at $16.6M in Q2 2025.
102 funds tracked by Wall St. Rank held LifeMD as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.